ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 120 filers reported holding ANIKA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $484,945 | -63.9% | 26,031 | -49.7% | 0.00% | -50.0% |
| Q2 2023 | $1,343,503 | +94713.2% | 51,713 | +4.8% | 0.00% | 0.0% |
| Q1 2023 | $1,417 | +4.5% | 49,322 | +7.6% | 0.00% | 0.0% |
| Q4 2022 | $1,356 | -99.9% | 45,825 | +1.1% | 0.00% | 0.0% |
| Q3 2022 | $1,079,000 | +10.3% | 45,317 | +3.4% | 0.00% | +100.0% |
| Q2 2022 | $978,000 | -9.5% | 43,815 | +1.8% | 0.00% | 0.0% |
| Q1 2022 | $1,081,000 | -28.2% | 43,056 | +2.4% | 0.00% | -50.0% |
| Q4 2021 | $1,506,000 | -16.4% | 42,043 | -0.7% | 0.00% | 0.0% |
| Q3 2021 | $1,802,000 | -11.1% | 42,350 | -9.6% | 0.00% | -33.3% |
| Q2 2021 | $2,027,000 | -2.0% | 46,824 | -7.7% | 0.00% | 0.0% |
| Q1 2021 | $2,069,000 | -5.8% | 50,726 | +4.5% | 0.00% | 0.0% |
| Q4 2020 | $2,197,000 | +42.1% | 48,545 | +11.1% | 0.00% | +50.0% |
| Q3 2020 | $1,546,000 | -12.1% | 43,691 | -6.2% | 0.00% | -33.3% |
| Q2 2020 | $1,758,000 | +21.2% | 46,584 | -7.1% | 0.00% | 0.0% |
| Q1 2020 | $1,450,000 | -41.3% | 50,146 | +5.3% | 0.00% | -25.0% |
| Q4 2019 | $2,470,000 | +0.2% | 47,639 | +6.1% | 0.00% | -20.0% |
| Q3 2019 | $2,464,000 | +40.7% | 44,883 | +4.1% | 0.01% | +66.7% |
| Q2 2019 | $1,751,000 | +36.2% | 43,118 | +1.4% | 0.00% | +50.0% |
| Q1 2019 | $1,286,000 | -9.2% | 42,538 | +0.9% | 0.00% | -33.3% |
| Q4 2018 | $1,417,000 | -6.9% | 42,172 | +16.8% | 0.00% | 0.0% |
| Q3 2018 | $1,522,000 | +32.7% | 36,092 | +0.7% | 0.00% | +50.0% |
| Q2 2018 | $1,147,000 | -31.9% | 35,848 | +5.8% | 0.00% | -50.0% |
| Q1 2018 | $1,684,000 | -5.9% | 33,876 | +2.1% | 0.00% | 0.0% |
| Q4 2017 | $1,789,000 | +8.8% | 33,181 | +17.1% | 0.00% | 0.0% |
| Q3 2017 | $1,644,000 | +20.2% | 28,345 | +2.3% | 0.00% | +33.3% |
| Q2 2017 | $1,368,000 | +14.0% | 27,720 | +0.3% | 0.00% | 0.0% |
| Q1 2017 | $1,200,000 | +25.9% | 27,624 | +42.0% | 0.00% | +50.0% |
| Q4 2016 | $953,000 | +5.2% | 19,455 | +2.7% | 0.00% | 0.0% |
| Q3 2016 | $906,000 | -4.4% | 18,935 | +7.2% | 0.00% | -33.3% |
| Q2 2016 | $948,000 | +14.1% | 17,670 | -4.9% | 0.00% | 0.0% |
| Q1 2016 | $831,000 | +21.1% | 18,575 | +3.3% | 0.00% | +50.0% |
| Q4 2015 | $686,000 | +28.5% | 17,990 | +7.2% | 0.00% | 0.0% |
| Q3 2015 | $534,000 | -2.6% | 16,780 | +1.2% | 0.00% | 0.0% |
| Q2 2015 | $548,000 | -19.4% | 16,589 | +0.5% | 0.00% | 0.0% |
| Q1 2015 | $680,000 | +15.3% | 16,514 | +14.0% | 0.00% | 0.0% |
| Q4 2014 | $590,000 | +8.5% | 14,489 | -2.4% | 0.00% | 0.0% |
| Q3 2014 | $544,000 | -18.4% | 14,839 | +3.1% | 0.00% | 0.0% |
| Q2 2014 | $667,000 | +8.6% | 14,389 | -3.8% | 0.00% | 0.0% |
| Q1 2014 | $614,000 | +3.5% | 14,950 | -3.8% | 0.00% | 0.0% |
| Q4 2013 | $593,000 | +90.7% | 15,540 | +19.6% | 0.00% | +100.0% |
| Q3 2013 | $311,000 | +40.7% | 12,990 | +0.1% | 0.00% | 0.0% |
| Q2 2013 | $221,000 | – | 12,972 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trigran Investments, Inc. | 1,154,183 | $25,761,000 | 3.00% |
| CAPITAL MANAGEMENT CORP /VA | 275,130 | $6,141,000 | 1.52% |
| Kent Lake Capital LLC | 98,570 | $2,200,000 | 1.21% |
| DIKER MANAGEMENT LLC | 21,835 | $487,000 | 0.60% |
| Portolan Capital Management | 235,972 | $5,267,000 | 0.53% |
| Riverwater Partners LLC | 12,466 | $278,000 | 0.28% |
| Ranger Investment Management | 139,661 | $3,117,000 | 0.24% |
| Invenomic Capital Management LP | 144,287 | $3,220,000 | 0.23% |
| CHATHAM CAPITAL GROUP, INC. | 23,787 | $531,000 | 0.12% |
| Teton Advisors, Inc. | 22,000 | $491,000 | 0.10% |